Orchid Cellmark Reports Third Quarter 2008 Financi...((In thousands) ...)

Date:11/18/2008

(In thousands) (Unaudited) September 30, December 31, 2008 2007 Assets: Current assets Cash and cash equivalents $15,857 $20,918 Accounts receivable, net 11,319 9,516 Inventory 1,497 1,443 Prepaids and other current assets 2,041 2,151 Total current assets 30,714 34,028 Fixed assets, net 6,399 7,440 Goodwill 9,558 9,519 Other intangibles, net 8,185 9,694 Restricted cash - 958 Other assets 487 490 Total assets $55,343 $62,129 Liabilities and Stockholders' Equity: Current liabilities Accounts payable $2,668 $2,027 Accrued expenses and other current liabilities 4,297 4,611 Income taxes payable - 543 Short-term debt and current portion of long-term debt 385 428 Deferred revenue 852 964 Total current liabilities 8,202 8,573 Other liabilities 284 1,123 Total liabilities 8,486 9,696 Total stockholders' equity 46,857 52,433
'/>"/>

SOURCE Orchid Cellmark Inc. Copyright©2008 PR Newswire. All rights reserved

2 GOOD

Page: 1 2 3 4 5 6 7 8
Related biology news :

1. Saving the wild orchids of Borneo
2. Orchid Cellmark to Present at the 2008 Bank of America Health Care Conference
3. First orchid fossil puts showy blooms at some 80 million years old
4. Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results
5. Synaptics Reports Record Results for First Quarter of Fiscal 2009
6. GEN reports on novel tools for deciphering biological networks
7. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
8. LSUHSC research reports new method to protect brain cells from diseases like Alzheimers
9. Communication Intelligence Corporation Reports Second Quarter 2008 Financial Results
10. BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008
11. BIO-key(R) Reports Profitability on Strong Revenue Growth for Second Quarter 2008